bullish
EOFlow (Further) Tests Investor Patience
1.4k Views24 Nov 2023 09:06
Medtronic needs to step up here, ahead of the next collateralised expiry date. EOFlow has overshot to the downside. Down 38% since the resumption of trading. If not in, I'd be picking up shares here.
Boomeranged on Tue, 5 Dec 2023 16:02
The Appellant Brief Is out. EOFlow flags. inter alia, the statute of limitations; whether Insulet faces a significant risk of irreparable harm; that the court misapplied trade secret law and failed to meaningfully weigh the balance of harms to the public interest; Insulet failed to identify trade secrets (or protect asserted trade secrets), and the differences between Insulet & EOFlow’s products.
SUMMARY
(Sign Up to Access)Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 4-minute read)
Discussions
(Paid Plans Only)
- EOFlow (Further) Tests Investor Patience24 Nov 2023
- EOFlow Craters. Medtronic Stays Mum16 Nov 2023
- AMD.The Best Is Yet To Come!26 Aug 2019
- Autonomous Driving- Are We There Yet?20 Mar 2018
x